Last reviewed · How we verify
Aridol
At a glance
| Generic name | Aridol |
|---|---|
| Sponsor | Syntara |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Boxed warnings
- WARNING: RISK OF SEVERE BRONCHOSPASM Mannitol, the active ingredient in ARIDOL, acts as a bronchoconstrictor and may cause severe bronchospasm. Bronchial challenge testing with ARIDOL is for diagnostic purposes only. Bronchial challenge testing with ARIDOL should only be conducted by trained professionals under the supervision of a physician familiar with all aspects of the bronchial challenge test and the management of acute bronchospasm. Medications (such as short-acting inhaled beta-agonist)
Common side effects
- Headache
- Pharyngolaryngeal pain
- Throat irritation
- Nausea
- Cough
- Rhinorrhea
- Dyspnea
- Chest discomfort
- Wheezing
- Retching
- Dizziness
- Gagging
Serious adverse events
- Severe Bronchospasm
Key clinical trials
- Effect of Infusion Warming on Mannitol Infusion Pain in Patients With Acute Ocular Hypertension (NA)
- Dose-dependent FODMAP Reintroduction in IBS (NA)
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
- Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) (PHASE2)
- Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia
- Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. (PHASE2)
- Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy (NA)
- Does Caffeine Facilitate Human Reward Learning Behaviors? (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aridol CI brief — competitive landscape report
- Aridol updates RSS · CI watch RSS
- Syntara portfolio CI